The lncRNA MEG3 has also been reported as a tumor suppressor in CRC cells by inhibiting c-Myc expression and indirectly reducing PKM2 activity, resulting in reduced glycolysis activity [57]. This evidence concerns the gene MEG3 and colorectal carcinoma.